new glp-1 agonists Receptor Agonists: The Wave in Diabetes Management GLP-1 receptor agonists show promise
Description
Less common risks include gallbladder disease and, in rare cases, pancreatitis
doi: 10.1172/JCI119482 129 XuGStoffersDAHabenerJFBonner-WeirS
About this Article Cite this article Article History DOI
The primary measure for long-term blood sugar is HbA1c, and studies show Tirzepatide can lower these levels by 1.24% to 2.58%
We then excluded patients that met any of the following criteria: (1) diagnosis with related disorders of the eyes excluding the retina based on the ICD-9 and ICD-10 codes (Additional file 1: Table S4)
The best timing for introducing oral semaglutide has not yet been established
